HemoSonics-UVA Spinal Surgery

NCT ID: NCT02418923

Last Updated: 2016-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-04-30

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in neurosurgery patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

HemoSonics is developing a novel POC diagnostic device, the Quantra System, to perform whole blood coagulation analysis and which is suitable for use in surgical and intensive care settings. The Quantra System employs a patented technology named sonorheometry, which was invented at the University of Virginia.

Sonorheometry uses ultrasound pulses to characterize the dynamic changes in viscoelastic properties of a blood sample during coagulation and clot lysis. The initial assay performed on the Quantra System will be the surgical assay for monitoring hemostasis during major surgical procedures in adult patients.

A clinical study will be conducted to evaluate the analytical performance as well as compared to existing coagulation monitoring technology

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deformity of Spine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Procedure: Blood specimen collection

Blood specimen collection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Subject is scheduled for major deformity correction spine surgery

* Subject is older than 18 years
* Subject is willing to participate and he/she has signed a consent form

Exclusion Criteria

* • Subject is unable to provide written informed consent

* Subject is incarcerated at the time of the study
* Subject is affected by any condition that, in the opinion of the surgical team, may pose additional risks
* Subjects with renal disease (defined as serum creatinine greater than 1.5 mg/dl)
* Subjects with history of active liver disease
* Subjects affected by Factor V Leiden mutation
* Subjects affected by von Willebrand disease
* Subjects with an history of thrombotic disease (more than one DVT)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HemoSonics LLC

INDUSTRY

Sponsor Role collaborator

University of Virginia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bhiken I. Naik, MD

UVA Anesthesiology Faculty

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bhiken Naik, MD

Role: PRINCIPAL_INVESTIGATOR

UVA Anethesiology Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Virginia

Charlottesville, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17942

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

rhBMP-2 in Cervical Arthrodesis
NCT02178605 COMPLETED
Discogen for Low Back Pain
NCT06611397 RECRUITING NA
LUMBAR & SACROILIAC FUSION STUDY
NCT07204288 RECRUITING NA
Clinical Outcome Measure at Stryker Spine
NCT06226272 NOT_YET_RECRUITING
Spinal Fusions Steroid Study
NCT05287035 UNKNOWN EARLY_PHASE1
Depo-Medrol on Psoas After LLIF
NCT05929755 RECRUITING PHASE4
Facet Wedge Post Market Study
NCT02203448 COMPLETED